Loading...
Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
Following the completion of the Fracture Prevention Trial, teriparatide was approved by the United States Food and Drug Administration and the European Medicine Agency as the first therapeutic anabolic agent for the treatment of postmenopausal women with severe osteoporosis. It subsequently received...
Na minha lista:
| Udgivet i: | Ther Adv Musculoskelet Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6778993/ https://ncbi.nlm.nih.gov/pubmed/31632472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X19877994 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|